Keywords: medimmune, initiates, ph, ii, trials, vitaxin, begun

MedImmune initiates two Ph II trials for Vitaxin

Article | 15 September 2003

Print This

MedImmune has begun two Phase II trials for its Vitaxin, a monoclonal antibody which targets the alpha-v-beta-3 integrin. One study ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in